bpc 157 vs tb500 comparison BPC-157 TB-500 BPC-157 vs TB-500: Comparing Recovery

The Substances on the Table These are the drugs being reviewed and the medical uses FDA will be evaluating: July 23, 2026: BPC-157 (free base and acetate) ulcerative colitis KPV (free base and acetate) wound healing and inflammatory conditions TB-500 (free base and acetate) wound healing MOTs-C (free base and acetate) obesity and osteoporosis July 24, 2026: Emideltide / DSIP (delta sleep-inducing peptide, free base and acetate) opioid withdrawal, chronic insomnia, and narcolepsy Semax (free base and acetate) cerebral ischemia, migraine, and trigeminal neuralgia Epitalon (free base and acetate) insomnia If any or all of these substances are added to the 503A Bulks List following this process, it would formalize the legal pathway for licensed pharmacists and physicians to compound them for patients

T., Bachleitner-Hofmann, T., Christensen, J

Dihexa is generally well tolerated when used under medical supervision, and most people report few side effects

However, clinical studies show no significant benefit in functional stability, patient reported outcomes or retear rates

REDEFINE 1 (Phase 3a, NEJM 2025) Garvey et al., n=3,417, 68 weeks

Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer